Hopkinson Craig C.

Insider

EVP R&D, Chief Medical Officer

Trades at: ALKS· ALBO

30D 90D 1Y

Net shares · 365d

-79.7K

0 buy · 79.7K sell

Net value · 365d

-$2.6M

$0 in · $2.6M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 79.7K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

ALKS Exercise·M
Jun 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +369%
ALKS Sell·S
Jun 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$375.0K

9.0K sh · $41.67

Own -10%
ALKS Exercise·M
Jun 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +6%
ALKS Exercise·M
May 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +79%
ALKS Sell·S
May 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$300.6K

9.0K sh · $33.40

Own -10%
ALKS Exercise·M
May 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +6%
ALKS Exercise·M
Apr 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +44%
ALKS Sell·S
Apr 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$319.6K

9.0K sh · $35.51

Own -10%
ALKS Exercise·M
Apr 1, 26

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +6%
ALKS Grant·A
Mar 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$0

121.6K sh · 2 lots

Own New
ALKS Exercise·M
Mar 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +31%
ALKS Exercise·M
Mar 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +5%
ALKS Sell·S
Mar 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$267.5K

9.0K sh · $29.72

Own -9%
ALKS Exercise·M
Feb 26, 26

EVP R&D, Chief Medical Officer

—

6.9K sh

Own +100%
ALKS Exercise·M
Feb 26, 26

EVP R&D, Chief Medical Officer

—

6.9K sh

Own +8%
ALKS Other·F
Feb 26, 26

EVP R&D, Chief Medical Officer

$93.7K

3.0K sh · $30.73

Own -3%
ALKS Exercise·M
Feb 23, 26

EVP R&D, Chief Medical Officer

—

7.7K sh

Own +768900%
ALKS Other·F
Feb 23, 26

EVP R&D, Chief Medical Officer

$109.9K

3.4K sh · $32.19

Own -4%
ALKS Exercise·M
Feb 23, 26

EVP R&D, Chief Medical Officer

—

7.7K sh

Own +9%
ALKS Exercise·M
Feb 19, 26

EVP R&D, Chief Medical Officer

—

16.6K sh · 2 lots

Own +257%
ALKS Other·F
Feb 19, 26

EVP R&D, Chief Medical Officer

$221.2K

6.9K sh · $32.01 avg · 2 lots

Own -7%
ALKS Exercise·M
Feb 19, 26

EVP R&D, Chief Medical Officer

—

16.6K sh · 2 lots

Own +23%
ALKS Grant·A
Feb 5, 26

EVP R&D, Chief Medical Officer

—

25.4K sh

Own +44%
ALKS Other·F
Feb 5, 26

EVP R&D, Chief Medical Officer

$250.1K

7.5K sh · $33.55

Own -9%
ALKS Exercise·M
Feb 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +23%
ALKS Sell·S
Feb 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$305.4K

9.0K sh · $33.93 avg · 2 lots

Own -13%
ALKS Exercise·M
Feb 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +8%
ALKS Exercise·M
Jan 8, 26

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +19%
ALKS Sell·S
Jan 8, 26

EVP R&D, Chief Medical Officer · 10b5-1

$150.0K

5.0K sh · $30.00

Own -7%
ALKS Exercise·M
Jan 8, 26

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +8%
ALKS Sell·S
Jan 2, 26

EVP R&D, Chief Medical Officer · 10b5-1

$112.0K

4.0K sh · $28.00

Own -6%
ALKS Exercise·M
Dec 3, 25

EVP R&D, Chief Medical Officer · 10b5-1

$0

3.7K sh

Own +11%
ALKS Sell·S
Dec 3, 25

EVP R&D, Chief Medical Officer · 10b5-1

$112.4K

3.7K sh · $30.00

Own -5%
ALKS Exercise·M
Dec 3, 25

EVP R&D, Chief Medical Officer · 10b5-1

$72.5K

3.7K sh · $19.34

Own +6%
ALKS Sell·S
Dec 1, 25

EVP R&D, Chief Medical Officer · 10b5-1

$117.2K

4.0K sh · $29.30

Own -6%
ALKS Exercise·M
Nov 3, 25

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +14%
ALKS Exercise·M
Nov 3, 25

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +7%
ALKS Sell·S
Nov 3, 25

EVP R&D, Chief Medical Officer · 10b5-1

$273.4K

9.0K sh · $30.38

Own -11%
ALKS Exercise·M
Oct 15, 25

EVP R&D, Chief Medical Officer · 10b5-1

$0

5.0K sh

Own +12%
ALKS Sell·S
Oct 15, 25

EVP R&D, Chief Medical Officer · 10b5-1

$283.8K

9.0K sh · $31.53

Own -11%
ALKS Exercise·M
Oct 15, 25

EVP R&D, Chief Medical Officer · 10b5-1

$96.7K

5.0K sh · $19.34

Own +6%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Jun 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+369%	—	$0
Jun 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-10%	$41.67	$375.0K
Jun 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+6%	$19.34	$96.7K
May 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+79%	—	$0
May 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-10%	$33.40	$300.6K
May 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+6%	$19.34	$96.7K
Apr 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+44%	—	$0
Apr 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-10%	$35.51	$319.6K
Apr 1, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+6%	$19.34	$96.7K
Mar 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Grant A	121.6K2 lots	New	—	$0
Mar 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+31%	—	$0
Mar 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+5%	$19.34	$96.7K
Mar 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-9%	$29.72	$267.5K
Feb 26, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	6.9K	+100%	—	—
Feb 26, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	6.9K	+8%	—	—
Feb 26, 2026	ALKS	EVP R&D, Chief Medical Officer	Other F	3.0K	-3%	$30.73	$93.7K
Feb 23, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	7.7K	+768900%	—	—
Feb 23, 2026	ALKS	EVP R&D, Chief Medical Officer	Other F	3.4K	-4%	$32.19	$109.9K
Feb 23, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	7.7K	+9%	—	—
Feb 19, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	16.6K2 lots	+257%	—	—
Feb 19, 2026	ALKS	EVP R&D, Chief Medical Officer	Other F	6.9K2 lots	-7%	$32.01 avg	$221.2K
Feb 19, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	16.6K2 lots	+23%	—	—
Feb 5, 2026	ALKS	EVP R&D, Chief Medical Officer	Grant A	25.4K	+44%	—	—
Feb 5, 2026	ALKS	EVP R&D, Chief Medical Officer	Other F	7.5K	-9%	$33.55	$250.1K
Feb 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+23%	—	$0
Feb 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K2 lots	-13%	$33.93 avg	$305.4K
Feb 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+8%	$19.34	$96.7K
Jan 8, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+19%	—	$0
Jan 8, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	5.0K	-7%	$30.00	$150.0K
Jan 8, 2026	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+8%	$19.34	$96.7K
Jan 2, 2026	ALKS	EVP R&D, Chief Medical Officer	Sell S	4.0K	-6%	$28.00	$112.0K
Dec 3, 2025	ALKS	EVP R&D, Chief Medical Officer	Exercise M	3.7K	+11%	—	$0
Dec 3, 2025	ALKS	EVP R&D, Chief Medical Officer	Sell S	3.7K	-5%	$30.00	$112.4K
Dec 3, 2025	ALKS	EVP R&D, Chief Medical Officer	Exercise M	3.7K	+6%	$19.34	$72.5K
Dec 1, 2025	ALKS	EVP R&D, Chief Medical Officer	Sell S	4.0K	-6%	$29.30	$117.2K
Nov 3, 2025	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+14%	—	$0
Nov 3, 2025	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+7%	$19.34	$96.7K
Nov 3, 2025	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-11%	$30.38	$273.4K
Oct 15, 2025	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+12%	—	$0
Oct 15, 2025	ALKS	EVP R&D, Chief Medical Officer	Sell S	9.0K	-11%	$31.53	$283.8K
Oct 15, 2025	ALKS	EVP R&D, Chief Medical Officer	Exercise M	5.0K	+6%	$19.34	$96.7K

Buy Sell Non-market (grant · exercise · gift)

About Hopkinson Craig C.

This profile aggregates every SEC Form 4 insider transaction reported by Hopkinson Craig C. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.